Oppenheimer Maintains Outperform on Hamilton Lane, Lowers Price Target to $181

Benzinga Newsdesk www.benzinga.com Negative 94.6%

Neg 94.6% Neu 0% Pos 0%

Oppenheimer analyst Chris Kotowski maintains Hamilton Lane (NASDAQ:HLNE) with a Outperform and lowers the price target from $182 to $181.